Northern Trust Corp Dare Bioscience, Inc. Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 183,302 shares of DARE stock, worth $78,819. This represents 0.0% of its overall portfolio holdings.

Number of Shares

183,302

Previous 183,302 -0.0%

Holding current value

$78,819

Previous $56,000 58.93%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.29 - $0.53 $6,375 - $11,652	21,986 Added 13.63%	183,302 $56,000
Q2 2023 Aug 11, 2023	SELL	$0.91 - $1.05 $320 - $369	-352 Reduced 0.22%	161,316 $146,000
Q2 2022 Aug 12, 2022	BUY	$0.94 - $1.76 $19,501 - $36,512	20,746 Added 14.72%	161,668 $199,000
Q1 2022 May 13, 2022	BUY	$1.42 - $2.09 $491 - $723	346 Added 0.25%	140,922 $210,000
Q4 2021 Feb 08, 2022	BUY	$1.42 - $2.13 $98,816 - $148,224	69,589 Added 98.03%	140,576 $281,000

Q3 2021 Nov 15, 2021	BUY	$1.42 - $2.0 $12,030 - $16,944	8,472 Added 13.55%	70,987 $119,000
Q1 2021 May 12, 2021	BUY	$1.31 - $3.0 $451 - $1,035	345 Added 0.55%	62,515 $106,000
Q4 2020 Feb 11, 2021	BUY	$0.96 - $1.51 $2,061 - $3,241	2,147 Added 3.58%	62,170 $83,000
Q3 2020 Nov 16, 2020	BUY	$0.98 - $1.52 $9,306 - $14,433	9,496 Added 18.79%	60,023 $60,000
Q2 2020 Aug 14, 2020	BUY	$0.84 - $1.11 $25,665 - $33,914	30,554 Added 152.98%	50,527 $50,000
Q1 2020 May 14, 2020	BUY	$0.79 - $1.7 $7,512 - $16,167	9,510 Added 90.89%	19,973 $17,000
Q2 2018 Aug 14, 2018	BUY	$0.76 - $1.48 $7,951 - $15,485	10,463 New	10,463 $12,000

Others Institutions Holding DARE

# of Institutions

Shares Held

6.86M

Call Options Held

Put Options Held

View Full List

About Dare Bioscience, Inc.

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $36.5M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

More about DARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Dare Bioscience, Inc. Transaction History